NCT06770101 Suicide Assessment and Feasible Evidence-based Treatments for Youth Living With HIV in Lilongwe
| NCT ID | NCT06770101 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pennsylvania |
| Condition | HIV |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-07-01 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overall aim of this study is to determine the feasibility, fidelity, acceptability, and preliminary effectiveness of the Friendship Bench +Safety Planning intervention in reducing suicidal ideation and behaviors (SIBs) and improving HIV engagement amongst adolescents living with HIV (ALWH) when compared to augmented usual care.
Eligibility Criteria
Inclusion Criteria: * Age 13-19 * Diagnosed with HIV * Report current or historical suicidal ideation and behaviors (SIBs) on question 9 of the Patient Health Questionnaire modified for adolescents (PHQ-9-A) and the Ask Suicide-Screening questionnaire (ASQ) * Living in the clinic's catchment area with intention to remain for more than 1 year * Willing to provide consent (age 18+ or 16-17 years old and married and thereby considered emancipated minors per Malawi law) or assent with parental consent (age 13-17). Exclusion Criteria: * Refuse to participate * Refuse to be audio-taped for in-depth interviews
Contact & Investigator
Melissa Stockton, PhD
PRINCIPAL INVESTIGATOR
University of Pennsylvania
Frequently Asked Questions
Who can join the NCT06770101 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, up to 19 Years, studying HIV. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06770101 currently recruiting?
Yes, NCT06770101 is actively recruiting participants. Contact the research team at melissaann.stockton@pennmedicine.upenn.edu for enrollment information.
Where is the NCT06770101 trial being conducted?
This trial is being conducted at Lilongwe, Malawi, Lilongwe, Malawi, Lilongwe, Malawi, Lilongwe, Malawi.
Who is sponsoring the NCT06770101 clinical trial?
NCT06770101 is sponsored by University of Pennsylvania. The principal investigator is Melissa Stockton, PhD at University of Pennsylvania. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.